Skip to content
WeighLab
Menu
Ranked #209 · Grade C

Oria Meds review

Oria Meds advertises compounded GLP-1s from $149 and $249, then offers $199 and $369 once you reach the plan menu, and never names either molecule on a public page.

Visit Oria Meds Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/month month-to-month (read in the intake; the homepage's $149 appears nowhere in the funnel)
Tirzepatide
$369/month month-to-month (the homepage's $249 appears nowhere in the funnel)
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$2,388

Tirzepatide · modeled / year

$4,428

Pricing verified September 2026

The Index scorecard

Oria Meds scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month54/100
Price Transparency36/100
Nationwide Access86/100
Formulation Options66/100
Clinical Oversight73/100
Contract Flexibility67/100

Where the value is

  • Names its compounding pharmacy, PerfectRx, with a street address, phone number and website
  • The monthly figure covers free shipping, a home injection kit, free dose increases and unlimited medical support, itemized on the plan card
  • Names the provider network behind the prescriptions rather than referring only to licensed clinicians
  • Charges nothing unless a provider issues a prescription, and states that the charge is refunded if none is issued
  • Cancellation is from the patient portal or by email, and stops all future charges

The tradeoffs

  • Neither published floor exists in the funnel: "starting at $149" and "starting at $249" appear nowhere in the plan menu, which offers $199 and $369
  • The semaglutide ladder is inverted — one month is $199 while three and six months are both $209 a month, so committing longer costs more
  • Neither semaglutide nor tirzepatide is named on any public page; the molecule appears only at step two of the intake, after your name, email, phone and shipping address are collected
  • The compounding class is claimed only inside an unrendered script; what a reader is actually told is "a licensed compounding pharmacy"
  • No legal entity, state of organization or governing law is published, so an enforcement screen against the operator cannot be run at all
  • No clinician name or NPI is published, and the legal name of the network behind the prescriptions is not given
  • Two scarcity counters run on consecutive screens with different numbers, and review turnaround is quoted as 24 hours in the intake and 48 at checkout
  • Medication is not refundable once dispensed, including unopened vials, so "cancel anytime" stops the next charge and nothing more

The bottom line

Best for: Readers who want the dispensing pharmacy named with an address and will complete the intake to see the real plan menu. Oria Meds advertises compounded GLP-1s from $149 and $249, then offers $199 and $369 once you reach the plan menu, and never names either molecule on a public page.

Ranked #209 of 529 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 528 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Oria Meds.

The 24 programs nearest this one

Pricing, states and verification reflect Oria Meds's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Oria Meds's site. Not medical advice; see our disclosure.

← Back to the value leaderboard